A proposed federal regulation would allow drug companies to sell brand-name drugs at monopoly prices for nearly all patients ...

Do you want to save money on your prescription drugs? If so, you are not alone. Many people face high drug costs that ...

The future of one of President Joe Biden’s key domestic policy achievements –– getting Medicare to negotiate drug prices –– ...

It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...

Proponents of the technology say it has the potential to make drug discovery faster and cheaper. In 2025 it may begin ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

However, rising medication costs and complex pharmacy benefit manager (PBM) practices are making it harder for rural ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

A recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between high- and low-income countries.

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

Implementing price controls that reference drug prices in other countries, as Sen. Sanders proposes, would eliminate the ...

In 2025, the standard monthly Medicare Part B premium is increasing from $174.70 to $185. And Part A enrollees will pay more ...